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The glycoprotein P-selectin, a membrane component of cell storage granules, is rapidly translocated from α-granules of platelets and the Weibel- Palade bodies 
of endothelial cells to the cell surface following an 
inflammatory process or other stimulations. P-selectin 
is a cell adhesion molecule of activated platelets and 
endothelial cells of interest because of its role in 
modulating interactions between blood cells and the 
endothelium, and also because of the possible use of 
its soluble form in plasma as a predictor of adverse 
cardiovascular events.1
In endothelial cells, within minutes of its stimu-
lation in vitro by inflammatory mediators, such as 
histamine, thrombin, or phorbol esters, or hypoxia, 
Weibel–Palade bodies are mobilized and their von 
Willebrand factor are degranulated. At the same time, 
P-selectin is also expressed at the surface as quick astwo 
minutes after stimulation. However, this expressionis 
short-lived, reaching its peak after only 10 minutes, 
declining back to baseline levels after 3 hours. Addi-
tional synthesis of P-selectin is brought about within 
2 hours by cytokines, such as interleukin-1 (IL-1), 
tumor necrosis factor-α (TNF-α), and by thrombin, 
lipopolysaccharide or oxygen radicals. Immunofluores-
cence and confocal laser cytometry are usually used to 
measure the translocation upon this activation.1
As P-selectin is originally defined on activated 
platelets and they are easier to obtain and study, there 
are considerably more data from platelet compared 
to endothelial ones. There are approximately 10.000 
P-selectin molecules on the surface of an activated 
platelet, translating to a density of perhaps 350 sites/
μm2, a density that exceeds even those on athrombin 
or histamine-stimulated endothelial cell in vitroby 
an approximate factor of ten. 1,2In this case, flow 
cytometry of activated platelet and microparticles was 
used to measure P-selectin.
The development of monoclonal antibody-based 
assay procedure (enzyme-linked immunosorbent assay 
(ELISA)) has allowed the quantification of P-selectin 
in fluids. The first commonly-asked question is: what 
is exactly beingmeasured? This point has arisen from 
the discovery of messenger RNA/cDNA coding for 
different variants of P-selectin, some of which coded 
for a molecule lacking a transmembrane portion, 
implying direct ‘secretion’ from the cell. It soon follows 
that the increased presence of a truncated soluble 
P-selectin isoform in plasma might reflectan increase 
in the activity of this form of message. Alternative 
mechanisms for the appearance of soluble P-selectin 
include simple shedding or active cleavage from cell 
surface, presumably by a non-specific enzyme or 
other mediator(s) that may arise from leukocytes, 
endothelium, or elsewhere. The second question 
often asked is: where does the P-selectin come from? 
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As P-selectin is present within both endothelial cells 
and the platelets, there has been considerable debate 
whether or not raised plasma levels of  P-selectin reflects 
endothelial dysfunction, platelet activation, or both. 
Overall, there are too few serious data to contradict 
the proposition that raised soluble P-selectin reflects 
platelet disturbance. Therefore, a soluble form of it, 
detectableby ELISA, may present in the blood mainly 
because of increased platelet activation.1,3Since soluble 
P-selectin is produced not only by endothelial cells 
but also, even mainly, by platelets, all factors affecting 
platelet activation should also be considered  as major 
contributors, in spite of production of endothelial 
P-selectin related to hemodynamic changes or reduced 
shear stress after percutaneous transvenous Balloon 
Mitral Valvulotomy(PBMV).
As mentioned, when soluble P-selectin is measured, 
confounding factors affecting P-selectin level should 
also be considered, such as previous treatment using 
calcium channel inhibitor, statin, anticoagulant and/
or antiplatelet. Cessation of smoking is also known to 
reduce soluble P-selectin.1
In mitral stenosis (MS), although there is a sig-
nificant increasein mitral valve area and significant 
decrease in mean left atrial and pulmonary arterial 
pressures immediately after PBMV, there were no 
significant immediate (10 minutes after PBMV) 
changes found in plasma atrial P-selectin. Therefore, 
persistent increase in plasma P-selectin levels after 
PBMV might be partly attributed to the persistent 
endothelial dysfunction after PBMV. Plasma soluble 
P-selectinlevels could not reflect changes in individual 
platelets, and there is an absenceof significant correla-
tions between the plasma levels of soluble P-selectin 
in the left atrium and left atrial volume index, all 
of which reported by Shanti et al, who used 20 
samples with wide variant of soluble P-selectin level 
from ELISA that resulted in big standard deviation. 
Similar results were also shown by Chen et al using 
the same sample size. However, previous studies with 
a larger sample size have shown significant decrease 
of left atrial Pselectin level at 24 hour, and 4 weeks 
after PBMV with no significant difference between 
peripheral and left atrial P-selectin.4,5 Hasan-Ali et 
al. showed that P-selectin change correlated with the 
change in left atrial diameter and pulmonary artery 
systolic pressure after 2 weeks of PBMV procedure 
in 65 patients. 5It may take a longer period of altered 
hemodynamic to reduce left atrial soluble P-selectin 
in MS patients following PBMV. 
Taken together, many factors affected the change of 
left atrial soluble P-selectin level after PBMV, such as 
its baseline level, the effect of drugs affecting P-selectin 
expression and the duration of measurement from 
PBMV procedure.  
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